Geneia leaders discuss AI and social determinants at HIMSS
February 7, 2019
Orlando FL – Geneia, a healthcare analytic solutions and services company that is simplifying the evolution to value-based care, announced today its leaders are speaking at HIMSS 2019 about the role of artificial intelligence (AI) and social determinants of health (SDoH) in population health and value-based care at HIMSS 2019.
“We’re thrilled to showcase how our provider, health system and payer clients are using Geneia’s analytics platform to identify and engage high and rising-risk patients such as the more than 84 million American adults with prediabetes, many of whom are at increased risk due to food, transportation and housing challenges,” said Geneia CEO Mark A. Caron, CHCIO, FACHE. “To learn how, come meet us at HIMSS booth #541 or attend one of our presentations:
Geneia Client and Partner Presentations at HIMSS
- February 12, 2:00-3:30 pm How CRM will Enable Patient Care Transformation Using Digital Tools
- February 12, 2:30-3:30 pm AI Fireside Chat hosted by Geneia CTO Fred Rahmanian
- February 12, 3:30-4:00 pm Using Social Determinants to Identify High-Risk Patients and Improve Outcomes
- February 13, 4:00-4:30 pm Improving Care Management with Predictive Analytics, CRM and Social Determinant Data
To learn more about Geneia’s HIMSS sessions, visit http://marketing.geneia.com/himss2019/.
Geneia LLC is a healthcare analytic solutions and services company that focuses on improving systems to support personalized, patient-centered care. We help clients improve outcomes, lower costs and restore the Joy of Medicine to physician practice. Our technology, education and training, insights and clinical services simplify the evolution to value-based care and drive alignment and collaboration among healthcare providers, health plans and employers. The company has offices in Harrisburg, PA and Manchester, NH. To learn more, visit Geneia.com or connect with us on Twitter, LinkedIn and Facebook.